{"id":"W3199488937","doi":"10.17863/cam.66211","title":"Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab.","year":2021,"lang":"en","type":"article","venue":"Edinburgh Research Explorer (University of Edinburgh)","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":163,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Infection and Immunity","funders":"NIHR Cambridge Biomedical Research Centre; NIHR Imperial Biomedical Research Centre; NIHR Newcastle Biomedical Research Centre; Public Health England; Dr. Falk Pharma; National Institute for Health and Care Research; Genentech; Royal Devon and Exeter NHS Foundation Trust; Galápagos; Vifor Pharma; Crohn's and Colitis UK; Public Health Wales; Leona M. and Harry B. Helmsley Charitable Trust; Celgene; Pfizer; Biogen; Sanofi; F. Hoffmann-La Roche; Celltrion; Roche; Amgen; IC Design Education Center; Celltrion Healthcare; Allergan; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Infliximab; Medicine; Vedolizumab; Internal medicine; Seroconversion; Concomitant; Gastroenterology; Serology; Immunology; Vaccination; Antibody; Ulcerative colitis; Tumor necrosis factor alpha; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001470099,0.0004844888,0.001167149,0.002249569,0.0004180118,0.00008568286,0.0006943871,0.0003555545,0.0003963976],"category_scores_gemma":[0.0008462682,0.0004382267,0.0001944174,0.005336971,0.001338723,0.0008230921,0.0005878017,0.00150574,0.00002549691],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000525224,"about_ca_system_score_gemma":0.001484621,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001085263,"about_ca_topic_score_gemma":0.0002809706,"domain_scores_codex":[0.9932368,0.0003966029,0.000419967,0.001260098,0.003186303,0.001500214],"domain_scores_gemma":[0.9937445,0.0006344811,0.0002142438,0.001228186,0.003957557,0.0002210301],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01337899,0.001792931,0.8836595,0.00009171748,0.0003827408,0.004868818,0.002271496,0.000002341981,0.07862319,0.00001022591,0.01412432,0.0007937216],"study_design_scores_gemma":[0.0313732,0.005241391,0.7246514,0.002587895,0.0002366146,0.00007860297,0.01954479,0.0005350243,0.1637456,0.00011644,0.05074741,0.001141636],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9945931,0.000208555,0.00008209987,0.001363376,0.00008655037,0.001126881,0.00005827312,0.000127007,0.002354112],"genre_scores_gemma":[0.9976896,0.00006252327,0.0003625299,0.0008965603,0.0001574158,0.00001118335,0.0001156877,0.00007151511,0.0006329886],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1590081,"threshold_uncertainty_score":0.9998069,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08125932260396923,"score_gpt":0.3493702546509735,"score_spread":0.2681109320470043,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}